These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


328 related items for PubMed ID: 9850029

  • 21. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O'Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL.
    Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):1089-96. PubMed ID: 11072167
    [Abstract] [Full Text] [Related]

  • 22. Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
    Ueno H, Okusaka T, Ikeda M, Tokuuye K.
    Oncology; 2004 Nov 01; 67(3-4):215-21. PubMed ID: 15557781
    [Abstract] [Full Text] [Related]

  • 23. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
    Stokes JB, Nolan NJ, Stelow EB, Walters DM, Weiss GR, de Lange EE, Rich TA, Adams RB, Bauer TW.
    Ann Surg Oncol; 2011 Mar 01; 18(3):619-27. PubMed ID: 21213060
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
    Carducci MA, Abrams RA, Yeo CJ, Hruban RH, Zahurak ML, Cameron JL, Grochow LB.
    Int J Radiat Oncol Biol Phys; 1996 Apr 01; 35(1):143-50. PubMed ID: 8641911
    [Abstract] [Full Text] [Related]

  • 27. Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis.
    Valentini V, Morganti AG, Macchia G, Mantini G, Mattiucci GC, Brizi MG, Alfieri S, Bossola M, Pacelli F, Sofo L, Doglietto G, Cellini N.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1094-9. PubMed ID: 18313525
    [Abstract] [Full Text] [Related]

  • 28. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
    Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA.
    J Clin Oncol; 2008 Jul 20; 26(21):3496-502. PubMed ID: 18640930
    [Abstract] [Full Text] [Related]

  • 29. Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas.
    Evans DB, Pisters PW, Lee JE, Bold RJ, Charnsangavej C, Janjan NA, Wolff RA, Abbruzzese JL.
    J Hepatobiliary Pancreat Surg; 1998 Jul 20; 5(3):242-50. PubMed ID: 9880770
    [Abstract] [Full Text] [Related]

  • 30. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 31. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Nukui Y, Picozzi VJ, Traverso LW.
    Am J Surg; 2000 May 15; 179(5):367-71. PubMed ID: 10930481
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study.
    Morganti AG, Picardi V, Ippolito E, Massaccesi M, Macchia G, Deodato F, Mattiucci GC, Caravatta L, Di Lullo L, Giglio G, Tambaro R, Mignogna S, Caprino P, Ingrosso M, Sofo L, Cellini N, Valentini V.
    Acta Oncol; 2010 May 15; 49(4):418-22. PubMed ID: 20397772
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma.
    Pisters PW, Ballo MT, Fenstermacher MJ, Feig BW, Hunt KK, Raymond KA, Burgess MA, Zagars GK, Pollock RE, Benjamin RS, Patel SR.
    J Clin Oncol; 2003 Aug 15; 21(16):3092-7. PubMed ID: 12915599
    [Abstract] [Full Text] [Related]

  • 37. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
    Hsu CC, Herman JM, Corsini MM, Winter JM, Callister MD, Haddock MG, Cameron JL, Pawlik TM, Schulick RD, Wolfgang CL, Laheru DA, Farnell MB, Swartz MJ, Gunderson LL, Miller RC.
    Ann Surg Oncol; 2010 Apr 15; 17(4):981-90. PubMed ID: 20087786
    [Abstract] [Full Text] [Related]

  • 38. [Preoperative radiochemotherapy in pancreatic cancer: preliminary results].
    Morganti AG, Trodella L, Valentini V, Doglietto GB, Ziccarelli P, Macchia G, Alfieri S, Smaniotto D, Luzi S, Brizi MG, Fadda G, Fiorino M, Di Gesú C, Cellini N.
    Tumori; 1999 Apr 15; 85(1 Suppl 1):S27-32. PubMed ID: 10235077
    [Abstract] [Full Text] [Related]

  • 39. Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head.
    Ohigashi H, Ishikawa O, Eguchi H, Sasaki Y, Yamada T, Noura S, Murata K, Takachi K, Miyashiro I, Doki Y, Imaoka S, Kasugai T, Nishiyama K.
    Ann Surg Oncol; 2005 Aug 15; 12(8):629-36. PubMed ID: 15968497
    [Abstract] [Full Text] [Related]

  • 40. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
    Mornex F, Girard N, Scoazec JY, Bossard N, Ychou M, Smith D, Seitz JF, Valette PJ, Roy P, Rouanet P, Ducreux M, Partensky C.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1471-8. PubMed ID: 16793214
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.